Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Erythropoietin Drugs Market to reach USD 7.7 billion by the end of 2030

Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-87306277
Publish Date: 29-02-2024
Page: 200

Global Erythropoietin Drugs Market is valued at approximately USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that stimulates the production of red blood cells in the bone marrow, a process known as erythropoiesis. Initially developed to address anemic conditions arising from End-Stage Renal Disease (ESRD) and related treatments such as dialysis, EPO drugs have expanded their applications. Following successful Post-abbreviated New Drug Application (ANDA) approvals, EPO drugs have been increasingly sanctioned for managing chemotherapy-induced anemia. The market growth is driven by key factors such as the rising incidence of chronic diseases and the rising number of CKD cases.

The growth can be attributed to the rising incidence of chronic diseases such as cancer, end-stage renal diseases, HIV, and neurological diseases. As per Statista, the prevalence of individuals experiencing at least two chronic diseases in Italy varied between 2010 and 2022, exhibiting an overall upward trend. In 2018, the peak was observed, with over 12.9 million people affected by at least two chronic diseases. By 2022, approximately 12.6 million Italians were grappling with at least two chronic diseases.. Furthermore, By the year 2050, it is anticipated that this number will surge to approximately 171 million. The prevalence of individuals with chronic conditions in the United States has been on a gradual rise since 1995. This data depicts the count of individuals with chronic medical conditions in the United States spanning from 1995 to 2020, along with projections for 2025 and 2050. However, the launch of alternative drugs and increased demand for EPO Side effects stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Erythropoietin Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the overall erythropoietin drugs market in terms of the revenue share of XX% in 2022. The regional market is anticipated to significantly benefit from local organizations that are actively engaged in advancing the development and use of erythropoietin drugs. Along with this, Asia Pacific is expected to witness fastest growth with CAGR XX% over the forecast period. The growth of the region is attributed to the presence of key players in the market and strategic initiatives undertaken by them to develop and commercialize new erythropoietin drug products to treat anemia patients.

Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Intas Pharmaceuticals Ltd.
Novartis AG
Amgen, Inc.
F. Hoffmann-La Roche Ltd.
LG Chem
Biocon
Sun Pharmaceutical Industries Ltd
Dr. Reddy’s Laboratories Ltd

Recent Developments in the Market:
Ø In November 2022, Dong-A ST forged a strategic partnership with Polifarma regarding the DA-3880 NESP biosimilar. This collaboration granted Polifarma the right to commercialize and advance the development of DA-3880 in the markets of Brazil, Mexico, and Turkey.

Ø In September 2021, Wanbang Biopharma obtained approval from the National Medical Products Administration (NMPA) for Yi Bao (Human Erythropoietin Injection). This approval signifies its intended use in addressing chemotherapy-related anemia in individuals with non-myeloid malignancies.

Global Erythropoietin Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Application, Type, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Erythropoietin
Darbepoetin-alfa

By Type:
Biologics
Biosimilars

By Application:
Cancer
Renal Diseases
Neurology
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Erythropoietin Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Erythropoietin Drugs Market, by Type, 2020-2030 (USD Billion)
1.2.3. Erythropoietin Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.4. Erythropoietin Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Erythropoietin Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Erythropoietin Drugs Market Dynamics
3.1. Erythropoietin Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of chronic diseases
3.1.1.2. Rising number of CKD cases
3.1.2. Market Challenges
3.1.2.1. Launch of alternative drugs
3.1.2.2. Increased demand for EPO Side effects
3.1.3. Market Opportunities
3.1.3.1. Rise in trends of commercialization for erythropoietin biosimilars
3.1.3.2. Increase in level of awareness regarding benefits of EPO therapeutics
Chapter 4. Global Erythropoietin Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Erythropoietin Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Erythropoietin Drugs Market by Type, Performance – Potential Analysis
5.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Erythropoietin Drugs Market, Sub Segment Analysis
5.4.1. Biologics
5.4.2. Biosimilars
Chapter 6. Global Erythropoietin Drugs Market, by Product
6.1. Market Snapshot
6.2. Global Erythropoietin Drugs Market by Product, Performance – Potential Analysis
6.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
6.4. Erythropoietin Drugs Market, Sub Segment Analysis
6.4.1. Erythropoietin
6.4.2. Darbepoetin-alfa
Chapter 7. Global Erythropoietin Drugs Market, by Application
7.1. Market Snapshot
7.2. Global Erythropoietin Drugs Market by Application, Performance – Potential Analysis
7.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Erythropoietin Drugs Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Renal Diseases
7.4.3. Neurology
7.4.4. Others
Chapter 8. Global Erythropoietin Drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Erythropoietin Drugs Market, Regional Market Snapshot
8.4. North America Erythropoietin Drugs Market
8.4.1. U.S. Erythropoietin Drugs Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Erythropoietin Drugs Market
8.5. Europe Erythropoietin Drugs Market Snapshot
8.5.1. U.K. Erythropoietin Drugs Market
8.5.2. Germany Erythropoietin Drugs Market
8.5.3. France Erythropoietin Drugs Market
8.5.4. Spain Erythropoietin Drugs Market
8.5.5. Italy Erythropoietin Drugs Market
8.5.6. Rest of Europe Erythropoietin Drugs Market
8.6. Asia-Pacific Erythropoietin Drugs Market Snapshot
8.6.1. China Erythropoietin Drugs Market
8.6.2. India Erythropoietin Drugs Market
8.6.3. Japan Erythropoietin Drugs Market
8.6.4. Australia Erythropoietin Drugs Market
8.6.5. South Korea Erythropoietin Drugs Market
8.6.6. Rest of Asia Pacific Erythropoietin Drugs Market
8.7. Latin America Erythropoietin Drugs Market Snapshot
8.7.1. Brazil Erythropoietin Drugs Market
8.7.2. Mexico Erythropoietin Drugs Market
8.8. Middle East & Africa Erythropoietin Drugs Market
8.8.1. Saudi Arabia Erythropoietin Drugs Market
8.8.2. South Africa Erythropoietin Drugs Market
8.8.3. Rest of Middle East & Africa Erythropoietin Drugs Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Teva Pharmaceutical Industries Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Johnson & Johnson Services, Inc.
9.3.3. Intas Pharmaceuticals Ltd.
9.3.4. Novartis AG
9.3.5. Amgen, Inc.
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.7. LG Chem
9.3.8. Biocon
9.3.9. Sun Pharmaceutical Industries Ltd
9.3.10. Dr. Reddy’s Laboratories Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now